Skip to main content
logo
Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.665
+0.145 (9.54%)
Nov 4, 2026, 5:25 PM CET

STO:NEWBRY Ratios and Metrics

Millions SEK. Fiscal year is Sep - Aug.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Market Capitalization
517679807887
Market Cap Growth
-20.71%-3.09%-1.65%2.52%-9.92%-
Enterprise Value
416267656548
Last Close Price
1.522.512.593.304.004.44

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Forward PE
-13.4513.45---
PS Ratio
1.081.722.492.177.6115.72
PB Ratio
2.443.891.841.541.581.26
P/TBV Ratio
--6.6315.9521.124.73

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
EV/Sales Ratio
0.871.392.121.766.358.70

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Net Debt / Equity Ratio
-0.48-0.48-0.34-0.29-0.17-0.48
Net Debt / EBITDA Ratio
0.500.500.741.120.482.40
Asset Turnover
0.580.580.380.450.130.09
Inventory Turnover
2.942.942.685.863.26-
Quick Ratio
0.620.621.161.272.045.63
Current Ratio
0.850.851.511.492.316.02
Return on Equity (ROE)
-73.51%-73.51%-50.46%-30.41%-32.89%-27.35%
Return on Assets (ROA)
-16.82%-16.82%-15.31%-11.04%-14.17%-13.48%
Return on Capital Employed (ROCE)
-102.10%-102.10%-44.30%-23.60%-29.60%-17.30%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Earnings Yield
-45.30%-30.05%-30.34%-19.24%-24.88%-16.92%
Buyback Yield / Dilution
-17.25%-17.25%-21.08%-9.68%-9.68%-